Equinox’s new Women’s Arc program merges biomarker testing, wearable insights, and hormone-aligned training to redefine women’s health, performance, and longevity.
Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with Astellas Pharma’s Veozah.
Pod, developed by Dr. Kesha Williams, aims to address feminine discomfort and initiate conversations about women's health.
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
Like with men, testosterone boosts sex drive and aggression in women, and limited studies show it may support bone health, as ...
Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center. Elinzanetant offers a hormone-free solution for managing ...
The therapist has the patient recall a painful event while guiding them through eye movements that mimic rapid eye movement ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
The hidradenitis suppurativa market is poised for strong growth, driven by increasing disease awareness, earlier diagnosis, and expanding treatment access. Advances in biologic and targeted therapies, ...
Leia’s journey with Hidradenitis Suppurativa (HS) began with a misdiagnosis, followed by a terrifying two-week period as her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback